Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rollover Study of Tifuvirtide (T-1249) for HIV
NCT00048217Phase 2Unknown
- Sponsor
- Trimeris, Inc.
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of tifuvirtide in human immunodeficiency virus infection (HIV), sponsored by Trimeris, Inc.. Status: unknown.
02
Drugs
tifuvirtide
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00048217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00048217.